Stem definition | Drug id | CAS RN |
---|---|---|
anti-inflammatory agents, ibuprofen derivatives | 833 | 22161-81-5 |
Dose | Unit | Route |
---|---|---|
75 | mg | O |
75 | mg | P |
None
None
MedDRA adverse event term | Likelihood ratio | Likelihood ratio threshold | Patients taking drug having adverse event | Patients taking drug not having adverse event | Patients not taking drug having adverse event | Patients not taking drug not having adverse event |
---|---|---|---|---|---|---|
Drug interaction | 55.10 | 42.85 | 42 | 1155 | 199579 | 50404348 |
Angioedema | 49.62 | 42.85 | 22 | 1175 | 37654 | 50566273 |
Lichen planus | 49.15 | 42.85 | 11 | 1186 | 1968 | 50601959 |
MedDRA adverse event term | Likelihood ratio | Likelihood ratio threshold | Patients taking drug having adverse event | Patients taking drug not having adverse event | Patients not taking drug having adverse event | Patients not taking drug not having adverse event |
---|---|---|---|---|---|---|
Hyperaesthesia | 61.33 | 33.82 | 15 | 786 | 3454 | 29570272 |
Quality of life decreased | 47.11 | 33.82 | 12 | 789 | 3250 | 29570476 |
Acute kidney injury | 40.12 | 33.82 | 42 | 759 | 265225 | 29308501 |
Hyperkalaemia | 34.16 | 33.82 | 21 | 780 | 61371 | 29512355 |
MedDRA adverse event term | Likelihood ratio | Likelihood ratio threshold | Patients taking drug having adverse event | Patients taking drug not having adverse event | Patients not taking drug having adverse event | Patients not taking drug not having adverse event |
---|---|---|---|---|---|---|
Acute kidney injury | 65.53 | 31.54 | 76 | 1999 | 449164 | 64047493 |
Angioedema | 56.33 | 31.54 | 31 | 2044 | 61790 | 64434867 |
Drug interaction | 52.24 | 31.54 | 61 | 2014 | 362022 | 64134635 |
Hyperbilirubinaemia | 44.97 | 31.54 | 19 | 2056 | 21186 | 64475471 |
Hyperaesthesia | 42.99 | 31.54 | 15 | 2060 | 9999 | 64486658 |
Hepatitis cholestatic | 40.15 | 31.54 | 15 | 2060 | 12140 | 64484517 |
Quality of life decreased | 38.60 | 31.54 | 13 | 2062 | 7793 | 64488864 |
Lichen planus | 34.19 | 31.54 | 9 | 2066 | 2319 | 64494338 |
Bradyphrenia | 32.50 | 31.54 | 12 | 2063 | 9394 | 64487263 |
Tubulointerstitial nephritis | 32.32 | 31.54 | 17 | 2058 | 30892 | 64465765 |
None
Source | Code | Description |
---|---|---|
ATC | M01AE17 | MUSCULO-SKELETAL SYSTEM ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS, NON-STEROIDS Propionic acid derivatives |
ATC | M02AA27 | MUSCULO-SKELETAL SYSTEM TOPICAL PRODUCTS FOR JOINT AND MUSCULAR PAIN TOPICAL PRODUCTS FOR JOINT AND MUSCULAR PAIN Antiinflammatory preparations, non-steroids for topical use |
ATC | N02AJ14 | NERVOUS SYSTEM ANALGESICS OPIOIDS Opioids in combination with non-opioid analgesics |
MeSH PA | D000700 | Analgesics |
MeSH PA | D018712 | Analgesics, Non-Narcotic |
MeSH PA | D000893 | Anti-Inflammatory Agents |
MeSH PA | D000894 | Anti-Inflammatory Agents, Non-Steroidal |
MeSH PA | D018501 | Antirheumatic Agents |
MeSH PA | D018373 | Peripheral Nervous System Agents |
MeSH PA | D018689 | Sensory System Agents |
CHEBI has role | CHEBI:35475 | non-steroidal anti-inflammatory agent |
CHEBI has role | CHEBI:50629 | COX-2 inhibitor |
CHEBI has role | CHEBI:50630 | COX-1 inhibitor |
None
None
None
Dissociation level | Dissociation constant | Type (acidic/basic) |
---|---|---|
pKa1 | 4.28 | acidic |
None
None
Target | Class | Pharos | UniProt | Action | Type | Activity value (-log[M]) | Mechanism action | Bioact source | MoA source |
---|---|---|---|---|---|---|---|---|---|
Prostaglandin G/H synthase 2 | Enzyme | INHIBITOR | IC50 | 7.57 | CHEMBL | KEGG DRUG | |||
Prostaglandin G/H synthase 1 | Enzyme | INHIBITOR | IC50 | 8.72 | CHEMBL | KEGG DRUG |
ID | Source |
---|---|
6KD9E78X68 | UNII |
D07269 | KEGG_DRUG |
233386 | RXNORM |
C0772505 | UMLSCUI |
CHEBI:76128 | CHEBI |
9KL | PDB_CHEM_ID |
CHEMBL75435 | ChEMBL_ID |
667550 | PUBCHEM_CID |
DB09214 | DRUGBANK_ID |
7120 | INN_ID |
C118296 | MESH_SUPPLEMENTAL_RECORD_UI |
007781 | NDDF |
007782 | NDDF |
329961001 | SNOMEDCT_US |
396018005 | SNOMEDCT_US |
427618005 | SNOMEDCT_US |
None